Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
-434K
-
Total reported value, excl. options
-
$1.77B
-
Value change
-
-$33.4M
-
Put/Call ratio
-
0.48
-
Number of buys
-
116
-
Number of sells
-
-74
-
Price
-
$79.45
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2024
241 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q3 2024.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 835M outstanding shares and own 2.67% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (2.24M shares), Robeco Institutional Asset Management B.V. (2.07M shares), Royal Bank of Canada (2M shares), RENAISSANCE TECHNOLOGIES LLC (1.95M shares), BlackRock, Inc. (1.92M shares), DIMENSIONAL FUND ADVISORS LP (1.06M shares), VANGUARD GROUP INC (985K shares), STATE STREET CORP (910K shares), BANK OF AMERICA CORP /DE/ (859K shares), and GOLDMAN SACHS GROUP INC (556K shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.